Aerpio Pharmaceuticals Statistics Share Statistics Aerpio Pharmaceuticals has 24.4M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 24.4M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 15.31M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.75M, so 0% of the outstanding
shares have been sold short.
Short Interest 2.75M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.83
Valuation Ratios The PE ratio is -0.93 and the forward
PE ratio is null.
Aerpio Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.93 Forward PE n/a PS Ratio 2.29 Forward PS n/a PB Ratio 1.13 P/FCF Ratio -0.97 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aerpio Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.59,
with a Debt / Equity ratio of 0.02.
Current Ratio 3.59 Quick Ratio 3.28 Debt / Equity 0.02 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 438.04
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $2.17M Profits Per Employee $-5.31M Employee Count 12 Asset Turnover 0.37 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.65, so Aerpio Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.65 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 401,776
Income Statement In the last 12 months, Aerpio Pharmaceuticals had revenue of 25.98M
and earned -63.69M
in profits. Earnings per share was -2.36.
Revenue 25.98M Gross Profit n/a Operating Income -67.46M Net Income -63.69M EBITDA -67.46M EBIT n/a Earnings Per Share (EPS) -2.36
Full Income Statement Balance Sheet The company has 28.67M in cash and 833K in
debt, giving a net cash position of 27.84M.
Cash & Cash Equivalents 28.67M Total Debt 833K Net Cash 27.84M Retained Earnings -332.65M Total Assets 234M Working Capital 220.34M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -59.55M
and capital expenditures -1.65M, giving a free cash flow of -61.2M.
Operating Cash Flow -59.55M Capital Expenditures -1.65M Free Cash Flow -61.2M FCF Per Share -2.26
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin -259.62% Pretax Margin -245.13% Profit Margin -245.13% EBITDA Margin -259.62% EBIT Margin -259.62% FCF Margin -235.55%
Dividends & Yields ARPO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ARPO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 27, 2021. It was a
backward
split with a ratio of 1:15.
Last Split Date Aug 27, 2021 Split Type backward Split Ratio 1:15
Scores Altman Z-Score 1.25 Piotroski F-Score 7
